ArticleRadiology2021
Increasing Access to Imaging for Addressing the Global Cancer Epidemic.
Abstract readEditorial
In one paragraph
Article in Radiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Sustainability in Radiology: Position Paper and Call to Action From ACR, AOSR, ASR, CAR, CIR, ESR, ESRNM, ISR, IS3R, RANZCR, and RSNA.Journal of medical imaging and radiation oncology · 2026Article
- Associations between fear of medical imaging radiation, risk perception, and patient decisional conflict: evidence from variable-centered and person-centered analyses.Frontiers in psychiatry · 2026Article
- Barriers and solutions in cross-sector care for metastatic prostate cancer patients in Germany: a qualitative study on radioligand therapy.BMC health services research · 2025Article
- Sustainability in radiology: position paper and call to action from ACR, AOSR, ASR, CAR, CIR, ESR, ESRNM, ISR, IS3R, RANZCR, and RSNA.European radiology · 2025Article
- Sustainability in Radiology: Position Paper and Call to Action From ACR, AOSR, ASR, CAR, CIR, ESR, ESRNM, ISR, IS3R, RANZCR, and RSNA.Korean journal of radiology · 2025Review
- Correlation of preoperative 18F-FDG-PET/CT tumor staging and maximum standardized uptake values with preoperative CT, postoperative tumor classification, and histopathological parameters of oral squamous cell carcinoma.Clinical oral investigations · 2025Article
- Artificial Intelligence-Enhanced Risk Stratification of Cancer Therapeutics-Related Cardiac Dysfunction Using Electrocardiographic Images.Circulation. Cardiovascular quality and outcomes · 2025Article
- Radiomic profiles improve prognostication and reveal targets for therapy in cervical cancer.Scientific reports · 2024Article
- Family Malvaceae: a potential source of secondary metabolites with chemopreventive and anticancer activities supported withFrontiers in pharmacology · 2024Article
- CT without borders: Comparison of diagnoses for abdominal pain from a teaching hospital in rural Kenya and a US academic medical center.Abdominal radiology (New York) · 2023Article
- Systematic approach to identify therapeutic targets and functional pathways for the cervical cancer.Journal, genetic engineering & biotechnology · 2023Article
- Nanotech Probes: A Revolution in Cancer Diagnosis.Frontiers in oncology · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Hedvig Hricak *From the Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065 (H.H., A.M.); Center for Health Decision Science (Z.J.W.) and Department of Global Health and Population (R.A.), Harvard T.H. Chan School of Public Health, Boston, Mass; Department of Global Health and Social Medicine, Harvard Medical School, Harvard University, Boston, Mass (R.A.); International Atomic Energy Agency, Division of Human Health, Vienna, Austria (M.A.W.); Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia (A.M.S.); Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Australia (A.M.S.); School of Cancer Medicine, La Trobe University, Melbourne, Australia (A.M.S.); and Department of Medicine, University of Melbourne, Melbourne, Australia (A.M.S.).ORCID 0000-0003-2240-9694
Zachary J WardFrom the Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065 (H.H., A.M.); Center for Health Decision Science (Z.J.W.) and Department of Global Health and Population (R.A.), Harvard T.H. Chan School of Public Health, Boston, Mass; Department of Global Health and Social Medicine, Harvard Medical School, Harvard University, Boston, Mass (R.A.); International Atomic Energy Agency, Division of Human Health, Vienna, Austria (M.A.W.); Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia (A.M.S.); Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Australia (A.M.S.); School of Cancer Medicine, La Trobe University, Melbourne, Australia (A.M.S.); and Department of Medicine, University of Melbourne, Melbourne, Australia (A.M.S.).ORCID 0000-0002-4007-2207
Rifat AtunFrom the Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065 (H.H., A.M.); Center for Health Decision Science (Z.J.W.) and Department of Global Health and Population (R.A.), Harvard T.H. Chan School of Public Health, Boston, Mass; Department of Global Health and Social Medicine, Harvard Medical School, Harvard University, Boston, Mass (R.A.); International Atomic Energy Agency, Division of Human Health, Vienna, Austria (M.A.W.); Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia (A.M.S.); Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Australia (A.M.S.); School of Cancer Medicine, La Trobe University, Melbourne, Australia (A.M.S.); and Department of Medicine, University of Melbourne, Melbourne, Australia (A.M.S.).ORCID 0000-0002-1531-5983
May Abdel-WahabFrom the Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065 (H.H., A.M.); Center for Health Decision Science (Z.J.W.) and Department of Global Health and Population (R.A.), Harvard T.H. Chan School of Public Health, Boston, Mass; Department of Global Health and Social Medicine, Harvard Medical School, Harvard University, Boston, Mass (R.A.); International Atomic Energy Agency, Division of Human Health, Vienna, Austria (M.A.W.); Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia (A.M.S.); Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Australia (A.M.S.); School of Cancer Medicine, La Trobe University, Melbourne, Australia (A.M.S.); and Department of Medicine, University of Melbourne, Melbourne, Australia (A.M.S.).ORCID 0000-0002-5415-1387
Ada Muellner *From the Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065 (H.H., A.M.); Center for Health Decision Science (Z.J.W.) and Department of Global Health and Population (R.A.), Harvard T.H. Chan School of Public Health, Boston, Mass; Department of Global Health and Social Medicine, Harvard Medical School, Harvard University, Boston, Mass (R.A.); International Atomic Energy Agency, Division of Human Health, Vienna, Austria (M.A.W.); Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia (A.M.S.); Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Australia (A.M.S.); School of Cancer Medicine, La Trobe University, Melbourne, Australia (A.M.S.); and Department of Medicine, University of Melbourne, Melbourne, Australia (A.M.S.).ORCID 0000-0002-5633-4531
Andrew M ScottFrom the Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065 (H.H., A.M.); Center for Health Decision Science (Z.J.W.) and Department of Global Health and Population (R.A.), Harvard T.H. Chan School of Public Health, Boston, Mass; Department of Global Health and Social Medicine, Harvard Medical School, Harvard University, Boston, Mass (R.A.); International Atomic Energy Agency, Division of Human Health, Vienna, Austria (M.A.W.); Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia (A.M.S.); Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Australia (A.M.S.); School of Cancer Medicine, La Trobe University, Melbourne, Australia (A.M.S.); and Department of Medicine, University of Melbourne, Melbourne, Australia (A.M.S.).ORCID 0000-0002-6656-295X
Funding
X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4MNCI NIH HHS P30 CA008748
Abstract
PubMed holds no abstract for this paper.
Indexed as
Healthcare DisparitiesInternationalityDelivery of Health CareDiagnostic ImagingEpidemicsHumansNeoplasms
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.